Back to Carlyle Group Inc. Carlyle Group Inc.

EFTREFTR
3 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in EFFECTOR THERAPEUTICS INC

No. Carlyle Group exited its EFTR (Effector Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 192,884 shares worth $55,936. Carlyle Group first reported EFTR in Q1 2024 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.7M

Total Shares Change

-192,884

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$0.04
0
2024-Q2
Unchanged
192,884
0.0%
$55,9360.0%$0.29
0
2024-Q1
New
192,884
-
$2.7M0.2%$14.39
44

Other major holders of EFTR: Ensign Peak Advisors, Inc, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used